Marc Pliskin, DO
Urology · Cincinnati, OHNPI 1174569362
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $80,035 of the $108,229 with a category attached, or 73.9%. Sumitomo Pharma America, Inc. accounts for 65.2% of it on its own, with 38 other manufacturers making up the rest. Reporting peaked in 2023 at $57,084 and has fallen 87.2% since, to $7,296 in 2025. Among urology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 538 payments — averaging $201.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$71K
- Myovant Sciences Inc.$14K
- Pfizer$7K
- Eli Lilly$3K
- Janssen Scientific Affairs, LLC$3K
- Boston Scientific$2K
- plus $10K from 33 others
Across 1,817 payments — averaging $11,380 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$6.9M
- Pfizer$6.2M
- Medivation LLC.$3.2M
- Janssen Research & Development, LLC$2M
- Bayer$730K
- AstraZeneca$669K
- plus $942K from 11 others
What the payments were for
- Consulting fees$5,7735%
- Speaking & faculty fees$80,03574%
- Travel & lodging$9,0758%
- Food & beverage$12,63212%
- Education$7151%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 41 | $70,581 |
| Myovant Sciences Inc. | 30 | $13,709 |
| Pfizer | 45 | $6,541 |
| Eli Lilly | 2 | $3,450 |
| Janssen Scientific Affairs, LLC | 8 | $2,591 |
| Boston Scientific | 50 | $1,783 |
| Astellas Pharma US Inc | 41 | $1,147 |
| Johnson & Johnson | 43 | $1,094 |
| Bayer | 58 | $955 |
| Dendreon Pharmaceuticals LLC | 36 | $946 |
| Merck | 15 | $883 |
| Coloplast | 62 | $734 |
| Palette Life Sciences, Inc. | 2 | $512 |
| AstraZeneca | 10 | $479 |
| Blue Earth Diagnostics | 14 | $422 |
| Tolmar Pharmaceuticals, Inc. | 12 | $224 |
| Calyxo, Inc. | 4 | $221 |
| Novartis | 4 | $189 |
| Progenics Pharmaceuticals, Inc. | 5 | $184 |
| Ferring Pharmaceuticals Inc. | 4 | $172 |
| Urogen Pharma, Inc. | 9 | $159 |
| Axonics, Inc. | 3 | $157 |
| Neotract Inc. | 1 | $146 |
| Myriad Genetic Laboratories, Inc. | 2 | $135 |
| Bioprotect Medical, Inc. | 1 | $117 |
| AbbVie | 7 | $111 |
| Foundation Medicine, Inc. | 2 | $96 |
| Amgen | 5 | $86 |
| Sun Pharmaceutical Industries Inc. | 4 | $72 |
| Immunitybio, Inc. | 1 | $67 |
| Endo Pharmaceuticals Inc. | 3 | $51 |
| Urovant Sciences Inc | 3 | $46 |
| Convatec Inc. | 1 | $43 |
| Clarus Therapeutics Inc. | 4 | $40 |
| Accord Healthcare, Inc. | 2 | $38 |
| ABC Home Medical Supply, Inc. | 1 | $13 |
| Procept Biorobotics Corporation | 1 | $13 |
| Antares Pharma, Inc. | 1 | $12 |
| Mission Pharmacal Company | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$108,229 in reported general payments places this provider in the 95th percentile of 485 urology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 37 | $123 |
Paid to pharmacies, not to this prescriber.
Other urology in Cincinnati
- Abhinav SidanaCincinnati$174K
- Paurush BabbarCincinnati$140K
- Stephen BennettCincinnati$38K
- Michael RousseauCincinnati$26K
- Kamal PoharCincinnati$20K
- Ryan FlynnCincinnati$16K
- Lawrence GervasiMiddleburg Heights$1.1M
- Howard GoldmanCleveland$721K
- Ronney AbazaWorthington$374K
- Sriharan SivalingamCleveland$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.